Catalyst Wire Dossier Catalyst Wire Dossier

Nefopam hydrochloride / paracetamol fixed-dose combination

nefopam hydrochloride and paracetamol · Unither Pharmaceuticals, France
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nefopam hydrochloride / paracetamol fixed-dose combination, covering 2024-10-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg) [Phase 1]

See pricing